John E. Kao (ALHC) reports multiple 10b5-1 stock sales through March 2026
Rhea-AI Filing Summary
ALHC reported Form 144 sales by or for John E. Kao under 10b5-1 plans. The excerpt lists multiple reported dispositions of Common stock, including sales of $1,133,514.66 across transactions on 12/29/2025 and repeated sales of $3,273,558.00 and similar amounts in early 2026. The filings show routine plan-based sales rather than corporate actions.
Positive
- None.
Negative
- None.
Insights
Reported sales are executed under pre-arranged 10b5-1 plans and represent routine dispositions.
The excerpt lists multiple Common stock sales attributed to John E. Kao and the JEK Trust U/A DTD 02/08/2021, including transactions on 01/12/2026 and 03/10/2026. Several entries explicitly cite a 10b5-1 Sales Plan, indicating pre‑arranged trading.
Cash flow recipients and aggregate remaining holdings are not disclosed in the excerpt; subsequent SEC filings would show settlement/stock‑count effects. The transactions are factual disclosures of dispositions, not company operational developments.